Genpact (NYSE:G) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, February 12th. Analysts expect the company to announce earnings of $0.42 per share for the quarter.
Genpact (NYSE:G) opened at $31.95 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $6,071.18, a PE ratio of 23.15, a P/E/G ratio of 1.95 and a beta of 0.57. Genpact has a fifty-two week low of $23.34 and a fifty-two week high of $34.79.
In other news, SVP Piyush Mehta sold 12,500 shares of Genpact stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $32.00, for a total transaction of $400,000.00. Following the completion of the transaction, the senior vice president now directly owns 77,944 shares in the company, valued at approximately $2,494,208. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Arvinder Singh sold 22,690 shares of Genpact stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $33.95, for a total value of $770,325.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,660,470 shares of company stock valued at $50,598,982. Corporate insiders own 1.41% of the company’s stock.
An institutional investor recently raised its position in Genpact stock. The Manufacturers Life Insurance Company lifted its holdings in shares of Genpact Limited (NYSE:G) by 7.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,508 shares of the business services provider’s stock after acquiring an additional 455 shares during the quarter. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 as of its most recent SEC filing. Institutional investors own 91.99% of the company’s stock.
A number of research firms have weighed in on G. Zacks Investment Research downgraded Genpact from a “buy” rating to a “hold” rating in a research note on Tuesday, January 9th. Cantor Fitzgerald restated a “buy” rating and issued a $36.00 price target on shares of Genpact in a research note on Wednesday, November 8th. Finally, Robert W. Baird restated a “buy” rating and issued a $38.00 price target on shares of Genpact in a research note on Friday, November 10th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Genpact has an average rating of “Buy” and a consensus price target of $33.38.
WARNING: “Genpact (G) Set to Announce Quarterly Earnings on Monday” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/02/11/genpact-g-set-to-announce-quarterly-earnings-on-monday.html.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.